期刊文献+

老年男性2型糖尿病患者血清内脂素水平与糖脂代谢的关系 被引量:8

Correlation of plasma visfatin and glucose lipid metabolism in elder male with type 2diabetes mellitus
原文传递
导出
摘要 目的探讨老年男性2型糖尿病(T2DM)患者血清内脂素水平与糖脂代谢的关系。方法采用酶联免疫吸附试验测定老年男性T2DM患者61例(A组)和非糖尿病老年男性患者57例(B组)血清内脂素水平,同时测定两组血压、空腹血糖、血脂水平,并计算胰岛素抵抗指数(HOMA-IR)、体重指数和腰臀比。结果 A组内脂素水平高于B组[(21.3±5.4)μg/L vs.(14.7±5.2)μg/L](P<0.05),内脂素水平与腰臀比和体重指数呈正相关(P<0.05)。结论老年男性T2DM患者血清内脂素水平增高;内脂素可能参与老年男性T2DM肥胖、胰岛功能受损的发生发展。 Objective To investigate the relationship between plasma visfatin level and glucose lipid metabolism in eldly male with type 2 diabetic mellitus(T2DM). Methods With ELISA method, plasma visfatin was examined in 61 elder patients with T2DM(group A) and 57 elder males without T2DM (group B). The body mass index (BMI), height, blood pressure, waist circumference, hip circumference, plasma lipids and fasting glucose were measured. The insulin resistance index (HOMA-IR) and waist-to-hip ratio(WHR) were calculated. Results Plasma visfatin was higher in group A than that in group B[(21.3±5.4)μg/L vs. (14. 7±5.2)μg/L] (P〈0. 05). Plasma level of visfatin was positively correlated with BMI and WHR (P〈0. 05). Conclusion Plasma levels of visfatin is increased in the elderly with T2DM. The visfatin appears to participate in the development of obesity and impaired islet function.
出处 《江苏医药》 CAS 北大核心 2014年第3期301-303,共3页 Jiangsu Medical Journal
基金 江苏省中医药管理局中医药科技项目课题资助(LZ09095)
关键词 内脂素 2型糖尿病 老年 Visfatin Type 2 diabetes mellitus Geriatrics
  • 相关文献

参考文献9

  • 1刘静,曹莉,田利民,钟建廷,郭茜.T2DM患者血浆内脏脂肪素、瘦素与胰岛素抵抗的相关性研究[J].中国糖尿病杂志,2008,16(9):521-523. 被引量:6
  • 2Dogrua T,Sonmeza A,Tascia I. Plasma visfatin levels in patients with new diagnosed and untreated type 2 diabetesmellitus and impaid glucose tolerance[J].{H}Diabetes Research and Clinical Practice,2007,(1):24-29.
  • 3Wang P,van Greevenbroek MM,Bouwman FG. The circulation PBEF/NAMPT/Visfatin level is associated with a beneficial blood lipid profile[J].{H}Pflugers Archives,2007,(6):971-976.
  • 4Li L,Yang G,Li Q. Changes and relations of circulation visfatin,apelin,an resistin levels in normal,impaired glucose tolerance,and type 2 diabetic subjects[J].J Exp Clin Endocrinol Diabetes,2006,(10):544-548.
  • 5Chang YC,Chang TJ,Lee WJ. The relationship of visfatin/pre2B2cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation,insulin resistance,and plasma lipids[J].{H}Metabolism-Clinical and experimental,2010,(1):93-99.
  • 6Haider DG,Schaller G,Kapiotis S. The release of the adipocytokine visfatin is regulated by glucose and insulin[J].{H}DIABETOLOGIA,2006,(8):1909-1914.
  • 7Bemdt J,Kloting N,Kralisch S. Plasma visfatin concentrations and fat depot-specific rnRNA expression in humans[J].{H}DIABETES,2005,(10):2911-2916.
  • 8Fukuhara A,Matsuda M,Nishizawa M. Visfatin:a protein secreted by visceral fat that mimics the effects of insulin[J].{H}SCIENCE,2005,(5708):426-430.
  • 9Chen MP,Chung FM,Chang DM. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus[J].{H}Journal of Clinical Endocrinology and Metabolism,2006,(1):295-299.

二级参考文献5

  • 1Kershaw EE,Flier JS. Adipose tissue as an ertdocrine organ. J Clin Endocrinol Metab, 2004,89 : 2548-2556.
  • 2Fukuhara A,Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science, 2005,307 : 426-430.
  • 3Haider DG, Schaller G, Kapiotis S, et al. The release of the adi poeytokine visfatin is regulated by glucose and insulin. Diabetolo gia, 2006,49:1909 1914.
  • 4Sethi JK,Vidal Puig A. Visfatin: the missing link between intra abdominal obes ty and diabetes? Trends Mol Med, 2005, 11:344-347
  • 5Moschen AR, Kaser A, Enrich B, et al. Visfatin,an adipocytokine with proinflammatory and immunomodulating properties. J Immunol, 2007, 178:1748- 1758.

共引文献5

同被引文献81

引证文献8

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部